AdaptHealth Corp. (AHCO) Fair Value 2026

AHCO · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.2 /10

32 fundamental signals · 12 models active

Value Trap Risk

SAFE (23/100)

Quick Summary — As of 2026-07-13, AdaptHealth Corp. (AHCO) trades at $10.29, approximately 374% above CirclFi’s Bayesian DCF fair value of $2.17. QOC: 7.2/10. Value Trap Risk: 23/100 (SAFE). 12/13 models active.

Key Facts

Ticker
AHCO
Price
$10.29
Quality Score
7.2/10
Value Trap Risk
23/100
Models Active
12/13
Last Updated
Strength: First Chicago suggests +69.2% upside with 55% confidence
Risk: Majority of models suggest overvaluation

Valuation Matrix

12 Intrinsic Value Models vs. Current Price ($10.29)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
$2.17 -78.9%
Earnings Power Value
High Conviction
$1.23 -88.1%
CUCE Ensemble
Low Conviction
$5.81 -43.5%
First Chicago
High Conviction
$17.41 +69.2%

Unlock the Full Matrix

Access 8 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 12 Models →

Cancel anytime · No contracts · Instant access

What Is AdaptHealth Corp. (AHCO) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on AdaptHealth Corp. at its current price of $10.29. The composite intrinsic value is estimated at $7.40 (-28.1% average return), with 8 models flagging overvaluation risk. Notably, RCMH-DCF sees the most upside at +99.7% (fair value: $20.54), while EPV is the most conservative at -88.1% ($1.23). The spread between these extremes — +187.7% — reveals how different analytical frameworks can reach starkly different conclusions. Among models with highest confidence, EPV lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About AHCO?

12 of 13 models are currently active for AHCO. Of these, 4 models suggest upside while 8 models suggest overvaluation. The Bayesian DCF estimates AHCO's intrinsic value at $2.17, implying -78.9% downside from the current price. See which stocks rank higher →

How Does AHCO Rank in Medical Devices?

Among 10 Medical Devices stocks, AHCO ranks #3 by Quality of Company score. CirclFi's QOC score of 7.2/10 evaluates 32 fundamental signals. A score of 7.2 indicates above-average quality.

As a healthcare company, AdaptHealth Corp. operates in a sector where pipeline depth and stage distribution is a critical driver of valuation. Investors evaluating AHCO should weigh these sector-specific dynamics alongside our model-derived fair values.

Is AHCO a Value Trap?

CirclFi's Value Trap algorithm assigns AHCO a score of 23/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

12 of 13 models are active for AdaptHealth Corp.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, AdaptHealth Corp.'s fundamental quality profile registers 7.2/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +187.7% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every AHCO valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across AHCO's 12 active models, average confidence is 44%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy AdaptHealth Corp. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

8 related Medical Devices stocks with 13-model coverage

Read investment analysis: ABT · AORT · APYX · AIDX · ADGM

Frequently Asked Questions About AdaptHealth Corp.

What is AdaptHealth Corp.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, AdaptHealth Corp. (AHCO) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $2.17. The Quality of Company score is 7.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is AHCO overvalued or undervalued right now?

At $10.29, 4 of 12 active models suggest AHCO may be undervalued, while 8 indicate potential overvaluation. The assessment depends on which methodology best fits AdaptHealth Corp.'s business model in Medical Devices.

What does a Quality of Company score of 7.2 mean for AHCO?

AdaptHealth Corp.'s QOC of 7.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on AHCO?

CirclFi analyzes AHCO with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 12 of 13 are active for this stock. Read the full methodology →

Is AHCO a value trap in 2026?

AdaptHealth Corp.'s Value Trap score is 23/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 12 mathematical frameworks give you clarity on AHCO.

Unlock All 12 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access